Characteristics of women with AIDS and invasive cervical cancer

Obstetrics and Gynecology

Volumn 88, Issue 2, 1996, Pages 269-273

  Klevens, R Monina ^a   Fleming, Patricia L ^a   Mays, Mitzi A ^a   Frey, Robert ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CANCER INVASION; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS INFECTION;

EID: 0030221798     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00186-X     Document Type: Article

References (33)

1. 1. Health, United States - 1993. National Center for Health Statistics, 1994. DHHS publication no. (PHS) 94-1232. Hyattsville Maryland: Public Health Service, 1994.
2. 2. Miller BA, Ries LAG, Hankey BF, Kosary CL, Harras A, Devesa SS, et al. SEER cancer statistics review: 1973-1990. NIH publication no. 93-2789. Bethesda, Maryland: National Cancer Institute, 1993.
3. 3. Provencher D, Valme B, Averette HE, Ganjei P, Donato GD, Penalver M, et al. HIV status and positive Papanicolau screening: Identification of a high-risk population. Gynecol Oncol 1988;31: 184-8.
4. 4. Henry MJ, Stanley MW, Cruikshank S, Carson L. Association of human immunodeficiency virus-induced immunosuppression with human papillomavirus infection and cervical intraepithelial neoplasia. Am J Obstet Gynecol 1989;160:352-3.
5. 5. Maiman M, Fruchter RG, Serur E, Remy JC, Feuer G, Boyce J. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990;38:377-82.
6. 6. Carpenter CCJ, Mayer KH, Stein MD, Leibman BD, Fisher A, Fiore T. Human immunodeficiency virus infection in North American women: Experience with 200 cases and a review of the literature. Medicine 1991;70:307-25.
7. 7. Mandelblatt JS, Fahs M, Garibaldi K, Senie RT, Peterson HB. Association between HIV infection and cervical neoplasia: Implications for clinical care of women at risk for both conditions. AIDS 1992;6:173-8.
8. 8. Cates W, Holmes KK. Sexually transmitted diseases. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last public health & preventive medicine. Norwalk, Connecticut: Appleton & Lange, 1988:99-114.
9. 9. Rellihan MA, Dooley DP, Burke TW, Berkland ME, Longfield RN. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol 1990;36:435-8.
10. 10. Schwartz LB, Carcangiu ML, Bradham L, Schwartz PE. Rapidly progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection: Clinical opinion. Gynecol Oncol 1991;41:255-8.
11. 11. Schrager LK, Friedland GH, Maude D, Schreiber K, Adachi A, Pizzuti DJ, et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1989;2:570-5.
12. 12. Schafer A, Friedmann W, Mielke M, Schwartlander B, Koch MA. The increased frequency of cervical dysplasia-neoplasia in women infected with HIV is related to the degree of immunosuppression. Am J Obstet Gynecol 1991;164:593-9.
13. 13. Feingold AR, Vermund SH, Burk RD, Kelley KF, Schrager LK, Schreiber K, et al. Cervical cytologic abnormalities and papillomavirus in women infected with HIV. J Acquir Immune Defic Syndr 1990;3:896-903.
14. 14. Vermund SH, Kelley KF, Klein RS, Feingold AR, Schreiber K, Munk G, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991;165:392-400.
15. 15. Laga M, Icenogle JP, Marsella R, Manoka AT, Nzila N, Ryder RW, et al. Genital papillomavirus infection and cervical dysplasia-opportunistic complications of HIV infection. Int J Cancer 1992;50: 45-8.
16. 16. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41(RR-17):1-19.
17. 17. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. Year-end edition. February 1993:22.
18. 18. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, Inc., 1989:140.
19. 19. Kim MY, Marmor M, Dubin N, Wolfe H. HIV risk-related sexual behaviors among heterosexuals in New York City: Associations with race, sex, and intravenous drug use. AIDS 1993;7:409-14.
20. 20. Farizo K, Kelly JJ, Buehler JW, Whyte BM, Mokotoff ED, Bell CE, et al. Provision of gynecologic care at outpatient medical facilities serving HIV-infected persons. J Women Health 1992;1:193-6.
21. 21. Hankins CA, Lamont JA, Handley MA. Cervicovaginal screening in women with HIV infection: A need for increased vigilance? Can Med Assoc J 1994;150:681-6.
22. 22. Adachi A, Fleming I, Burk RD, Ho GYF, Klein RS. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: A prospective study of colposcopy and clinical outcome. Obstet Gynecol 1993;81:372-7.
23. 23. Wright TC Jr, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7.
24. 24. Marte C, Kelly P, Cohen M, Fruchter RG, Sedlis A, Gallo L, et al. Papanicolaou smear abnormalities in ambulatory care sites for women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1992;166:1232-7.
25. 25. Hu DJ, Frey R, Costa SJ, Massey J, Ryan J, Fleming PL, et al. Geographical AIDS rates and socio-demographic variables in the Newark, New Jersey metropolitan area. AIDS Public Policy J 1994;9:20-5.
26. 26. Siegel PZ, Frazier EL, Mariolis P, Brackbill RM, Smith C. Behavioral risk factor surveillance, 1991: Monitoring progress toward the nation's year 2000 health objectives. MMWR 1993;42:1-30.
27. 27. Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL. Gender differences in reported AIDS-indicative diagnoses. J Infect Dis 1993;168:61-7.
28. 28. Monforte AA, Vago L, Lazzarin A, Boldorini R, Bini T, Guzzetti S, et al. AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS 1992; 6:1159-64.
29. 29. Afessa B, Greaves W, Green W, Olopoenia L, Delapenha R, Saxinger C, et al. Autopsy findings in HIV-infected inner-city patients. J Acquir Immune Defic Syndr 1992;5:132-6.
30. 30. Chu SY, Buehler JW, Berkelman RL. Impact of the human immunodeficiency virus epidemic on mortality in women of reproductive age, United States. JAMA 1990;264:225-9.
31. 31. Buehler JW, Hanson DL, Chu SY. The reporting of HIV/AIDS deaths in women. Am J Public Health 1992;82:1500-5.
32. 32. Centers for Disease Control and Prevention. Update: Impact of the expanded AIDS surveillance case definition for adolescents and adults on case reporting - United States, 1993. MMWR 1994;43: 160-1, 167-70.
33. 33. Centers for Disease Control and Prevention. AIDS in women -United States. MMWR 1990;39:845-6.